Opendata, web and dolomites

BioMensio SIGNED

BioMensio mobile biosensing platform: the first truly palm-sized and accurate digital multi-drug test

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 BioMensio project word cloud

Explore the words cloud of the BioMensio project. It provides you a very rough idea of what is the project "BioMensio" about.

solutions    centre    surpassed    heavy    detect    administrate    market    biomensio    virtually    deployment    bio    sensing    spin    alcohol    platform    accuracy    provides    understand    deaths    paramedics    performance    ready    device    off    accurate    proof    fatal    reduce    drivers    fatalities    first    rapid    sized    driving    fuelled    accelerator    found    siemens    minutes    machinery    people    suited    billion    intoxication    war    drug    finland    designed    bulkiness    employers    variety    legalisation    workplace    helps    million    government    saliva    worldwide    person    palm    influence    tools    stringent    hampered    prevent    exceeds    patented    narcotics    simultaneously    globally    norms    levels    patient    traffic    injuries    preventative    deploying    uncertain    backed    instrumentation    caused    mechanism    coming    efficient    company    inability    drugs    illicit    mass    mishandling    vtt    drugged    police    stage    drive    accidents   

Project "BioMensio" data sheet

The following table provides information about the project.

Coordinator
BIOMENSIO OY 

Organization address
address: HERMIANKATU 6-8 H
city: TAMPERE
postcode: 33720
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Finland [FI]
 Total cost 3˙560˙030 €
 EC max contribution 2˙492˙021 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-2
 Funding Scheme SME-2
 Starting year 2019
 Duration (year-month-day) from 2019-03-01   to  2021-02-28

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    BIOMENSIO OY FI (TAMPERE) coordinator 2˙492˙021.00

Map

 Project objective

In the EU, well over 8 million people have been found to drive under the influence of illicit drugs. In the US, fatal traffic accidents caused by drugged driving has already surpassed alcohol-induced traffic deaths. Drug intoxication testing is an efficient mechanism that helps to avoid drug related fatalities, such as traffic accidents or heavy machinery mishandling. However, the current testing solutions are not suited for wide scale deployment and thus cannot make a meaningful impact in the war against drugs. They are hampered by the bulkiness and high cost of instrumentation, uncertain levels of accuracy, and inability to detect the growing variety of drugs.

BioMensio multi-drug testing platform is the first palm-sized and highly accurate device to detect drug intoxication from saliva, designed specifically for the police to detect drugged drivers, paramedics to better understand patient condition, and employers to prevent workplace injuries. Our patented bio-sensing technology enables to simultaneously measure a person’s intoxication from virtually any widely used narcotics, in an easy-to-administrate test that provides results in just 1-2 minutes. This by far exceeds the performance of any other current or up-and-coming technology.

BioMensio is a spin-off company from Siemens Technology Accelerator and VTT Technical Research Centre of Finland, and has been backed with €3.5 million early stage funding. We are now beyond the proof-of-concept phase and are ready to scale our technology. We target the globally growing €1 billion saliva-based rapid drug testing market, which is fuelled by increasingly stringent government norms and workplace drug testing legalisation worldwide. As the key to reduce drug related fatalities and injuries is widely deploying and applying preventative tools, the main goal of our project is bring our patented bio-sensing platform to the mass market.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "BIOMENSIO" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "BIOMENSIO" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

COPI (2020)

Carbon Offset Plug-in

Read More  

Magnesys (2019)

Efficient filtering of metallic impurities in food processing

Read More  

DeltaQon (2019)

IOT and cloud computing for online medical analysis service platform

Read More